stockrow
Friday 6 November 2026
Export CELC’s income statement to Excel — free account
Celcuity, Inc.
CELC Healthcare Biotechnology
- EPS
- −38.5%
- Free cash flow
- −53.3%
- Total debt
- +658.7%
Quarter to June 2026, against a year earlier
66.82
2.78
+4.34%
Follow CELC
Alert me
Celcuity, Inc. (CELC) Operating cash flow
Celcuity, Inc.'s operating cash flow for fiscal 2025 was −$153.3M, compared with −$83.5M in fiscal 2024. Over the twelve months to 30 June 2026 it was −$191.7M. Over the past ten years it has ranged from −$153.3M (fiscal 2025) to −$2.0M (fiscal 2015) — the current reading is the lowest in ten years. Operating cash flow has fallen for 6 consecutive fiscal years. Celcuity, Inc. ranks 542nd of 603 Biotechnology companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | −$153.3M | — |
| FY2024 | −$83.5M | — |
| FY2023 | −$53.8M | — |
| FY2022 | −$36.0M | — |
| FY2021 | −$20.3M | — |
| FY2020 | −$7.1M | — |
| FY2019 | −$6.0M | — |
| FY2018 | −$6.1M | — |
| FY2017 | −$4.9M | — |
| FY2016 | −$2.9M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | −$55.4M | — |
| Mar 2026 | −$55.1M | — |
| Dec 2025 | −$36.4M | — |
| Sep 2025 | −$44.8M | — |
| 38 more quarters | Free account |
Against its own ten years
Low −$153.3M
High −$2.0M
Ten-year median
−$7.1M
Current reading's percentile
9
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| TLX Telix Pharmaceuticals Limited compare | $51.9M |
| TARS Tarsus Pharmaceuticals, Inc. compare | $49.9M |
| ELVN Enliven Therapeutics, Inc. compare | −$66.9M |
| CELC Celcuity, Inc. | −$191.7M |
| VRDN Viridian Therapeutics, Inc. compare | −$341.5M |
| IDYA IDEAYA Biosciences, Inc. compare | −$347.4M |
| DNLI Denali Therapeutics Inc. compare | −$444.2M |
| VKTX Viking Therapeutics, Inc. compare | −$462.6M |
| DYN Dyne Therapeutics, Inc. compare | −$477.8M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item